Gapping down
In reaction to disappointing earnings/guidance:
- WBA -7.2%, ANGO -7.2%
M&A news:
- MIDD -1.8% (acquires Powerhouse Dynamics; terms not disclosed)
- LEA -1% (to acquire Xevo for $320 mln)
Other news:
- APYX -36% (Apyx Medical has voluntarily withdrawn its application for premarket notification 510(k) regulatory clearance of J-Plasma/Renuvion for use in dermal resurfacing procedures; IDE study misses primary efficacy endpoint; sees Q1 revenue above estimates; reaffirms FY19 revenue)
- EVOP -5.2% (proposes underwritten offering of 5 mln shares of its Class A common stock)
- TCDA -3.8% (files for 5 mln share common stock offering)
- OCUL -3.2% (files for 9,574,020 share common stock offering by selling stockholders)
- CRCM -1.9% (releases statement to "correct inaccuracies appearing in several recent media reports"; downgraded to Neutral from Buy at BTIG Research)
- CVS -1.9% (in sympathy with WBA)
- BILI -1.6% (proposes to offer up to $300 mln of convertible senior notes due 2026; files for shelf offering of Class Z ordinary shares represented by American depositary shares)
- STAG -1.2% (prices public offering of 6,500,000 shares of its common stock for gross proceeds of ~ $190.1 million)
Analyst comments:
- LYFT -4.4% (initiated with a Sell at Seaport Global Securities; tgt $42)
- AA -1% (downgraded to Neutral from Outperform at Credit Suisse)
- PACB -1% (downgraded to Equal-Weight from Overweight at Stephens)